Conformational Analysis of Free and Bound Retinoic Acid.
暂无分享,去创建一个
[1] U. Ryde,et al. The protonation status of compound II in myoglobin, studied by a combination of experimental data and quantum chemical calculations: quantum refinement. , 2004, Biophysical journal.
[2] C. Bloomfield,et al. All-trans-retinoic acid in acute promyelocytic leukemia. , 1997, The New England journal of medicine.
[3] Kenneth M Merz,et al. QM/MM X-ray refinement of zinc metalloenzymes. , 2010, Journal of inorganic biochemistry.
[4] H P Koeffler,et al. Ligands for peroxisome proliferator-activated receptorgamma and retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in vitro and in BNX mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[5] Satoru Miyano,et al. Open source clustering software , 2004 .
[6] K. White,et al. Genomic Antagonism between Retinoic Acid and Estrogen Signaling in Breast Cancer , 2009, Cell.
[7] T. Kakitani,et al. Comprehensive study of molecular conformation and adiabatic potential surface of all-trans retinal by the CNDO/2 method , 1990 .
[8] Lucia Altucci,et al. Design of selective nuclear receptor modulators: RAR and RXR as a case study , 2007, Nature Reviews Drug Discovery.
[9] A. Dalgleish,et al. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-γ and altered expression of Bcl-2/Bax , 2002, British Journal of Cancer.
[10] E. Dmitrovsky,et al. Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid). , 1991, The New England journal of medicine.
[11] Peter Gruss,et al. Homeotic transformations of murine vertebrae and concomitant alteration of Hox codes induced by retinoic acid , 1991, Cell.
[12] B. Shroot,et al. Synthesis, structure-affinity relationships, and biological activities of ligands binding to retinoic acid receptor subtypes. , 1995, Journal of medicinal chemistry.
[13] G. Krupitza,et al. Retinoic acid receptors in retinoid responsive ovarian cancer cell lines detected by polymerase chain reaction following reverse transcription. , 1993, British Journal of Cancer.
[14] W. Hendrickson. Stereochemically restrained refinement of macromolecular structures. , 1985, Methods in enzymology.
[15] Zhen-yi Wang,et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. , 1988, Haematology and blood transfusion.
[16] W. Thiel,et al. Quantum refinement of protein structures: implementation and application to the red fluorescent protein DsRed.M1. , 2010, The journal of physical chemistry. B.
[17] Ulf Ryde,et al. Quantum refinement of [FeFe] hydrogenase indicates a dithiomethylamine ligand. , 2010, Journal of the American Chemical Society.
[18] Alok J. Saldanha,et al. Java Treeview - extensible visualization of microarray data , 2004, Bioinform..
[19] P. Fernhoff,et al. Retinoic acid embryopathy. , 1985, The New England journal of medicine.
[20] Targacept active conformation search: a new method for predicting the conformation of a ligand bound to its protein target. , 2004, Journal of medicinal chemistry.
[21] Babak Borhan,et al. Structural analysis of site-directed mutants of cellular retinoic acid-binding protein II addresses the relationship between structural integrity and ligand binding. , 2008, Acta crystallographica. Section D, Biological crystallography.
[22] C. Glass,et al. Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators , 1998, Nature.
[23] Kristina Nilsson,et al. Protonation status of metal-bound ligands can be determined by quantum refinement. , 2004, Journal of inorganic biochemistry.
[24] Xue Li,et al. QM/MM refinement and analysis of protein bound retinoic acid , 2012, J. Comput. Chem..
[25] T. A. Jones,et al. Crystal structures of cellular retinoic acid binding proteins I and II in complex with all-trans-retinoic acid and a synthetic retinoid. , 1995, Structure.
[26] W. Bollag. Arotinoids. A new class of retinoids with activities in oncology and dermatology. , 1981, Cancer chemotherapy and pharmacology.
[27] Kenneth M Merz,et al. Refinement of protein crystal structures using energy restraints derived from linear-scaling quantum mechanics. , 2005, Acta crystallographica. Section D, Biological crystallography.
[28] H. Gronemeyer,et al. Characterization of the Interaction between Retinoic Acid Receptor/Retinoid X Receptor (RAR/RXR) Heterodimers and Transcriptional Coactivators through Structural and Fluorescence Anisotropy Studies* , 2005, Journal of Biological Chemistry.
[29] Ilme Schlichting,et al. Crystal structures of substrate-free and retinoic acid-bound cyanobacterial cytochrome P450 CYP120A1. , 2008, Biochemistry.
[30] L. Gudas,et al. Retinoids, retinoic acid receptors, and cancer. , 2011, Annual review of pathology.
[31] Ulf Ryde,et al. Identification of the peroxy adduct in multicopper oxidases by a combination of computational chemistry and extended X-ray absorption fine-structure measurements. , 2007, Journal of the American Chemical Society.
[32] Maria Carmo-Fonseca,et al. Retinoic acid regulates aberrant nuclear localization of PML-RARα in acute promyelocytic leukemia cells , 1994, Cell.
[33] J. Karle,et al. Crystal Structure of the Visual Chromophores, 11-cis and all-trans Retinal , 1971, Nature.
[34] W. Miller. The emerging role of retinoids and retinoic acid metabolism blocking agents in the treatment of cancer , 1998, Cancer.
[35] Kristina Nilsson,et al. Quantum chemical geometry optimizations in proteins using crystallographic raw data , 2002, J. Comput. Chem..
[36] Xiao He,et al. Conformational variability of benzamidinium-based inhibitors. , 2009, Journal of the American Chemical Society.
[37] K. Merz,et al. Further analysis and comparative study of intermolecular interactions using dimers from the S22 database. , 2009, The Journal of chemical physics.
[38] Xue Li,et al. Accurate assessment of the strain energy in a protein‐bound drug using QM/MM X‐ray refinement and converged quantum chemistry , 2011, J. Comput. Chem..
[39] Conformational analysis of retinoids and restriction of their dynamics by retinoid-binding proteins. , 1996, The Biochemical journal.
[40] M. Gottardis,et al. Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand. , 1996, Cancer research.
[41] M. Sporn,et al. Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifen. , 1994, Cancer research.
[42] P. Wade,et al. Cancer biology and NuRD: a multifaceted chromatin remodelling complex , 2011, Nature Reviews Cancer.
[43] Michael Levitt,et al. Refinement of Large Structures by Simultaneous Minimization of Energy and R Factor , 1978 .
[44] Kenneth M Merz,et al. Critical assessment of quantum mechanics based energy restraints in protein crystal structure refinement , 2006, Protein science : a publication of the Protein Society.
[45] H. Yoshiji,et al. Inhibition by N-(4-hydroxyphenyl)retinamide and all-trans-retinoic acid of exogenous and endogenous development of putative preneoplastic, glutathione S-transferase placental form-positive lesions in the livers of rats. , 1997, Carcinogenesis.
[46] Jean-Paul Renaud,et al. Crystal structure of the RAR-γ ligand-binding domain bound to all-trans retinoic acid , 1995, Nature.
[47] Kenneth M Merz,et al. Assigning the protonation states of the key aspartates in β-Secretase using QM/MM X-ray structure refinement. , 2006, Journal of chemical theory and computation.
[48] Kristina Nilsson,et al. Quantum chemistry can locally improve protein crystal structures. , 2003, Journal of the American Chemical Society.
[49] R J Read,et al. Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.